Consultant Medical Oncologist - Gastrointestinal Cancer inChelsea inChelsea PUBLISHED 28 OCT 2024

Band Consultant: £105,504 to £139,882 a year per annum  FIXED TERM 
The post-holder will work as part of the GI Cancers Liquid Biopsy team in the GI Unit, recently established and supported by the NIHR and the GI unit, with one area of focus being in genomics and blood based biomarkers.

This is a new position for a Consultant in Medical Oncology with an interest in gastrointestinal (GI) cancers, working primarily at TheRoyal Marsden but in close collaboration with The Institute of Cancer Research (ICR). The post is part funded by theNational Institute for Health and Care Research (NIHR) RM/ICR Biomedical Research Centre (BRC).

The Royal Marsden, together with its academic partner The ICR, is designated as the UK's only NIHR BRC dedicated solely to cancer.

The GI Unit, which spans the Chelsea and Sutton sites, is world renowned for clinical care and clinical research related to patients with gastrointestinal cancers. All tumours of the gastrointestinal tract are treated including oesophago-gastric, colorectal, hepato-biliary and neuroendocrine cancers. Clinical and translational research is fully integrated within the unit alongside standard of care treatment pathways. Training the next generation of clinicians (both junior doctors and clinical research fellows) is also an integral part of the Unit's remit.

The GI Unit has a large integrated clinical research team of over 40 people comprising clinical research fellows (many of whom are supported to undertake higher degrees), research nurses, project managers, clinical trial co-ordinators, clinical trial administrators and biological specimen coordinators. It has one of the largest academic and commercial clinical trial portfolios in the Trust and leads national multicentre trials through the Royal Marsden Clinical Trials Unit. National and international collaboration is integral to the Unit's research strategy.

The post-holder will work as part of the GI Cancers Liquid Biopsy team in the GI Unit, recently established and supported by the NIHR and the GI unit, with one area of focus being in genomics and blood based biomarkers. The post holder will work with the relevant BRC Themes including but not limited to Precision Diagnostics and cancer Evolution (PDCE), Precision Therapeutics, Immunotherapeutics, Early Drug Development, Cancer Treatment Effects and Imaging and Data Science as applied to GI cancers.

About us


Please find the Job Description & Person Specification for further details on what the job will entail.

Objectives include:

  • Participate in multidisciplinary care provided by the GI Unit.
  • Supervision (clinical and educational) of doctors in training, undertaking teaching.
  • Collaboration with Industry partners to attract trials of innovative drugs or technology for GI cancers, especially in those tumour types with the highest unmet need and with innovations that have the most potential to impact outcomes.
  • Working with the Director for the NIHR Clinical Research Facility to maintain and potentially increase the portfolio of early phase trials (Phase Ib and II) in GI cancers.
  • To work with the Royal Marsden Clinical Trials Unit to maintain and potentially increase the portfolio of RM-sponsored academic trials in GI cancers.

This is a new position for a Consultant in Medical Oncology with an interest in gastrointestinal (GI) cancers, working primarily at TheRoyal Marsden but in close collaboration with The Institute of Cancer Research (ICR). The post is part funded by theNational Institute for Health and Care Research (NIHR) RM/ICR Biomedical Research Centre (BRC).

The Royal Marsden, together with its academic partner The ICR, is designated as the UK's only NIHR BRC dedicated solely to cancer.

The GI Unit, which spans the Chelsea and Sutton sites, is world renowned for clinical care and clinical research related to patients with gastrointestinal cancers. All tumours of the gastrointestinal tract are treated including oesophago-gastric, colorectal, hepato-biliary and neuroendocrine cancers. Clinical and translational research is fully integrated within the unit alongside standard of care treatment pathways. Training the next generation of clinicians (both junior doctors and clinical research fellows) is also an integral part of the Unit's remit.

The GI Unit has a large integrated clinical research team of over 40 people comprising clinical research fellows (many of whom are supported to undertake higher degrees), research nurses, project managers, clinical trial co-ordinators, clinical trial administrators and biological specimen coordinators. It has one of the largest academic and commercial clinical trial portfolios in the Trust and leads national multicentre trials through the Royal Marsden Clinical Trials Unit. National and international collaboration is integral to the Unit's research strategy.

The post-holder will work as part of the GI Cancers Liquid Biopsy team in the GI Unit, recently established and supported by the NIHR and the GI unit, with one area of focus being in genomics and blood based biomarkers. The post holder will work with the relevant BRC Themes including but not limited to Precision Diagnostics and cancer Evolution (PDCE), Precision Therapeutics, Immunotherapeutics, Early Drug Development, Cancer Treatment Effects and Imaging and Data Science as applied to GI cancers.

About us


Please find the Job Description & Person Specification for further details on what the job will entail.

Objectives include:

  • Participate in multidisciplinary care provided by the GI Unit.
  • Supervision (clinical and educational) of doctors in training, undertaking teaching.
  • Collaboration with Industry partners to attract trials of innovative drugs or technology for GI cancers, especially in those tumour types with the highest unmet need and with innovations that have the most potential to impact outcomes.
  • Working with the Director for the NIHR Clinical Research Facility to maintain and potentially increase the portfolio of early phase trials (Phase Ib and II) in GI cancers.
  • To work with the Royal Marsden Clinical Trials Unit to maintain and potentially increase the portfolio of RM-sponsored academic trials in GI cancers.



Locations are approximate. Learn more